Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India.
Jyoti BajpaiPritesh MunotKishore KotaGaurav GuptaKunal GalaAashish GuliaBharat RekhiNehal KhannaNitin Sudhakar ShettyPrabhat BhargavaSujay SrinivasVikas OstwalVijay Maruti PatilVanita NoronhaSuyash Sureshchandra KulkarniSiddhartha LaskarKumar PrabhashGirish ChinnaswamySudeep GuptaShripad BanavaliPublished in: JCO global oncology (2024)
The novel, low-cost MT qualifies as one of the effective, less toxic, sustainable, standard-of-care options for the treatment of DF with global reach and merits wide recognition.